Remove 2016 Remove Competition Remove Patients Remove Physicians
article thumbnail

Comparison of Humira biosimilars in the US and Europe

Pharmaceutical Technology

Biosimilars are an important tool to facilitate competition, lower the price of drugs, and create savings across the board. However, it has taken over six years for Amjevita to launch, after first being FDA-approved in 2016. Many other biosimilars have also been FDA-approved since 2016.

article thumbnail

Redesigning Provider Incentives to Influence Practice Patterns and Performance

Clarify Health

1] In a separate, controlled study, 80 percent of primary care physicians receiving micro-incentives referred patients to higher-value specialists they had never used before — representing a significant reduction in the total cost of care. Healthcare (2016), [link] [2] Parikh, R. million on orthopedic MS-DRGs.[1]

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Improving trial predictability: leveraging AI-powered analytics to guide trial design, strategy, and operations

pharmaphorum

Enrolling for clinical trials has become more challenging in recent years, with trial competition, increasingly complex protocols, and precision medicine targeting more niche patient populations. These potential study risks can lead to costly deviations and amendments, enrolment difficulties, and reduced patient compliance.

article thumbnail

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve!

PharmaKinnex

The pharmaceutical industry of 2022 is very different from the space that we all knew in 2012, 2016, or even 2020. From new legislation to functional shifts in marketing and advertising, the pharma industry works hard every day to keep up with new regulatory requirements and the constantly evolving expectations of prescribers and patients.

Pharma 52
article thumbnail

Virtual Reality Training For Medical Device Sales Reps With David Howe

Evolve Your Success

With VR simulations, sales reps can now hone their skills in lifelike scenarios, giving them a competitive edge in the field. There are mountains of data points, clinical studies and validation that’s been done to show that these products and techniques have a significant impact on patient outcomes. Osso was founded in 2016.

article thumbnail

Gene therapies transform rare disease treatment: hope for patients amidst regulatory, payer and developer challenges

Clarivate

Food and Drug Administration advisory committee’s narrow 8-6 vote in favor of recommending accelerated approval for a first-in-class gene transfer therapy was welcomed by Duchenne muscular dystrophy (DMD) patients and caregivers. Most patients must use a wheelchair by the time they are in their teens.

article thumbnail

Pharma’s post-pandemic launch performance problem: what’s the prognosis?

pharmaphorum

The initial pandemic lockdowns prevented many patients from seeing doctors face-to-face. Telemedicine rose dramatically in many countries, providing a route to managing ongoing care which was a lifeline for many patients. Therefore, the challenge of patient journeys disrupted or abandoned by the pandemic impacted less.

Doctors 57